Navigation Links
UBC geneticist reveals molecular view of key epigenetic regulator

In a paper published this week in the journal Proceedings of the National Academy of Sciences, Dr. Michael Kobor reported the structure and function of a key player in regulating chromatin in yeast and humans.

Kobor is a UBC assistant professor of medical genetics and a scientist at The Centre for Molecular Medicine and Therapeutics at the Child & Family Research Institute.

Chromatin, a dynamic DNA-protein complex, is involved in numerous cellular processes and has profound effects on human health and disease. This study is a major advancement in elucidating the role and structure of an epigenetic regulator commonly involved in human leukemia and other human diseases.

Chromatin biology is central to epigenetics which is a framework for environmental regulation of genome function. The chromatin regulator Yaf9 contains a module called the YEATS domain, which is found in many other proteins implicated in chromatin regulation and cancer. The molecular structure and function of YEATS domain proteins has been an unresolved mystery in the field of epigenetics.

Using advanced X-ray crystallography, the team gained the first detailed picture at atomic resolution of the YEATS domain. Furthermore, the authors showed that its function is conserved from yeast to human, and revealed a requirement of the YEATS domain for two different mechanisms by which chromatin can be modified.


Contact: Nicki Kahnamoui
University of British Columbia

Page: 1

Related biology news :

1. Geneticists coordinate action to fight against traffic in human beings
2. UC Riverside geneticist receives highest honor from Botanical Society of America
3. Is love at first sight real? Geneticists offer tantalizing clues
4. Ancient African exodus mostly involved men, geneticists find
5. Powerful online tool for protein analysis provided pro bono by Stanford geneticist
6. UC Riverside rice geneticist receives high honor from US Department of Agriculture
7. Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
8. Columbia geneticists uncover new gene involved in determining hair texture and density in humans
9. Plant geneticists find veritas in vino
10. Study reveals how Arctic food webs affect mercury in polar bears
11. Research reveals exactly how coughing is triggered by environmental irritants
Post Your Comments:
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
(Date:3/18/2016)... 18, 2016 --> ... ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance ... in the border security market and the continuing migration crisis ... Europe has led visiongain to publish this ... --> defence & security companies in the ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology: